Earnings · Hong Kong stocks

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) earnings

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H published its quarterly report on 2026-08-19. The stock moved -15.45% in the 3 trading days after the report.

Report
quarterly report
Published
2026-08-19
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-9.63%—
3 days-15.45%—
7 days-12.76%—
14 days-15.71%—
30 days-8.64%—

Report history

Over the last 2 reports, EPS beat the consensus estimate in 0 of them. The stock rose in the 3 trading days after 0 of 2 reports (average -10.58%).

PublishedEPSEPS surprise3 days after30 days after30d vs index
2026-08-190.34-23.44%-15.45%-8.64%-5.80%
2025-10-270.20-3.63%-5.71%-6.83%-1.58%

The last 2 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: 1276

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.